ROCKΔ1 acts as a novel fibrotic factor that induces pathological cardiac fibrosis and diastolic dysfunction through TGFβ1 and NF-κB signaling pathways.
No takes yet. Share an insight, caveat, or question.
Rho kinase inhibition attenuates fibrotic cardiomyopathy in mice; leaves open therapeutic translation to human diastolic dysfunction.
Yang et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: